These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16710552)

  • 21. The essential drugs concept is needed now more than ever.
    Smith MK; Tickell S
    Trans R Soc Trop Med Hyg; 2003; 97(1):2-5. PubMed ID: 12886792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The close connection between classical rights and the right to health, with special reference to the right to sexual and reproductive health.
    Hendriks A
    Med Law; 1999; 18(2-3):225-42. PubMed ID: 10536388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Access to essential medicines in 195 countries: A human rights approach to sustainable development.
    Perehudoff SK; Alexandrov NV; Hogerzeil HV
    Glob Public Health; 2019 Mar; 14(3):431-444. PubMed ID: 30187828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential medicines for children.
    Hoppu K; Sri Ranganathan S
    Arch Dis Child; 2015 Feb; 100 Suppl 1():S38-42. PubMed ID: 25613966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
    Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM
    Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals.
    Guan X; Hu H; Man C; Shi L
    Int J Equity Health; 2018 Oct; 17(1):158. PubMed ID: 30340587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Withdrawn medicines included in the essential medicines lists of 136 countries.
    Charles O; Onakpoya I; Benipal S; Woods H; Bali A; Aronson JK; Heneghan C; Persaud N
    PLoS One; 2019; 14(12):e0225429. PubMed ID: 31791048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 25 years of the WHO essential medicines lists: progress and challenges.
    Laing R; Waning B; Gray A; Ford N; 't Hoen E
    Lancet; 2003 May; 361(9370):1723-9. PubMed ID: 12767751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right to health, essential medicines, and lawsuits for access to medicines--a scoping study.
    Vargas-Peláez CM; Rover MR; Leite SN; Rossi Buenaventura F; Farias MR
    Soc Sci Med; 2014 Nov; 121():48-55. PubMed ID: 25306409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
    Ooms G; Forman L; Williams OD; Hill PS
    BMC Int Health Hum Rights; 2014 Dec; 14():37. PubMed ID: 25518744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Socio-cultural and service delivery dimensions of maternal mortality in rural central India: a qualitative exploration using a human rights lens.
    Jat TR; Deo PR; Goicolea I; Hurtig AK; San Sebastian M
    Glob Health Action; 2015; 8():24976. PubMed ID: 25840595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The selection and use of essential medicines. Report of the WHO expert committee, 2005 (including the 14th model list of essential medicines).
    World Health Organ Tech Rep Ser; 2006; (933):1-119, back cover. PubMed ID: 17566509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The selection and use of essential medicines.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2008; (950):backcover, vii-174. PubMed ID: 18754303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model list of essential medicines).
    World Health Organ Tech Rep Ser; 2003; 914():i-vi, 1-126. PubMed ID: 12872478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The morally uncomfortable global drug gap.
    Cohen-Kohler JC
    Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monographs for medicines on WHO's Model List of Essential Medicines.
    Roth L; Adler M; Jain T; Bempong D
    Bull World Health Organ; 2018 Jun; 96(6):378-385. PubMed ID: 29904220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The selection and use of essential medicines.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2009; (958):1-242, back cover. PubMed ID: 20560299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using international human rights law to improve child health in low-income countries: a framework for healthcare professionals.
    O'Hare BA; Devakumar D; Allen S
    BMC Int Health Hum Rights; 2016 Mar; 16():11. PubMed ID: 27029469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patents and access to essential drugs.
    Loff B
    Trans R Soc Trop Med Hyg; 2003; 97(1):6-9. PubMed ID: 12886793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.